Blobaum AL, Marnett LJ. Structural and functional basis of cyclooxygenase inhibition. J Med Chem 2007; 50(7): 1425-41.
Zhao S, Cheng CK, Zhang C-L, Huang Y. Interplay be-tween oxidative stress, cyclooxygenases, and prostanoids in cardiovascular diseases. Antioxid Redox Signal 2021; 34(10): 784-99.
Sheng J, Sun H, Yu F-B, Li B, Zhang Y, Zhu Y-T. The role of cyclooxygenase-2 in colorectal cancer. Int J Med Sci 2020; 17(8): 1095.
Rieger JM, Shah AR, Gidday JM. Ischemia-reperfusion injury of retinal endothelium by cyclooxygenase-and xanthine oxidase-derived superoxide. Exp Eye Res 2002; 74(4): 493-501.
Hla T, Bishop-Bailey D, Liu C, Schaefers H, Trifan OC. Cyclooxygenase-1 and-2 isoenzymes. Int J Biochem Cell Biol 1999; 31(5): 551-7.
Brooks P, Emery P, Evans J, Fenner H, Hawkey C, Patrono C, et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology 1999; 38(8): 779-88.
Zidar N, Odar K, Glavac D, Jerse M, Zupanc T, Stajer D. Cyclooxygenase in normal human tissues–is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med 2009; 13(9b): 3753-63.
Smith WL, Langenbach R. Why there are two cyclooxy-genase isozymes. J Clin Invest 2001; 107(12): 1491-5.
Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56(3): 387-437.
Chandel P, Rawal RK, Kaur R. Natural products and their derivatives as cyclooxygenase-2 inhibitors. Future Med Chem 2018; 10(20): 2471-92.
Rouzer CA, Marnett LJ. Cyclooxygenases: structural and functional insights. J Lipid Res 2009; 50: S29-S34.
Rouzer CA, Marnett LJ. Structural and chemical biology of the interaction of cyclooxygenase with substrates and non-steroidal anti-inflammatory drugs. Chem Rev 2020; 120(15): 7592-641.
DaiIley OD, Wang X, Chen F, Huang G. Anticancer activ-ity of branched-chain derivatives of oleic acid. Anticancer Res 2011; 31(10): 3165-9.
Yang C, Li P, Ding X, Sui HC, Rao S, Hsu C-H, et al. Mechanism for the reactivation of the peroxidase activity of human cyclooxygenases: investigation using phenol as a reducing cosubstrate. Sci Rep 2020; 10(1): 15187.
Manoj KM. Murburn posttranslational modifications of proteins: Cellular redox processes and murzyme-medi-ated metabolo-proteomics. J Cell Physiol 2024; 239(3): e30954.
Manoj KM, Jaeken L. Synthesis of theories on cellular powering, coherence, homeostasis and electro-mechan-ics: Murburn concept and evolutionary perspectives. J Cell Physiol 2023; 238(5): 931-53.
Manoj KM, Baburaj A, Ephraim B, Pappachan F, Ma-viliparambathu PP, Vijayan UK, et al. Explaining the atypical reaction profiles of heme enzymes with a novel mechanistic hypothesis and kinetic treatment. PLoS One 2010; 5(5): e10601.
Parashar A, Jacob VD, Gideon DA, Manoj KM. Hemo-globin catalyzes ATP-synthesis in human erythrocytes: a murburn model. J Biomol Struct Dyn 2022; 40(19): 8783-95.
Manoj KM, Gideon DA, Jaeken L. Interaction of mem-brane-embedded cytochrome b-complexes with quinols: Classical Q-cycle and murburn model. Cell Biochem Funct 2022; 40(2): 118-26.
Manoj KM, Nirusimhan V, Parashar A, Edward J, Gideon DA. Murburn precepts for lactic-acidosis, Cori cycle, and Warburg effect: Interactive dynamics of dehydrogenases, protons, and oxygen. J Cell Physiol 2022; 237(3): 1902-22.
Manoj KM, Gideon DA, Bazhin NM, Tamagawa H, Nirusimhan V, Kavdia M, et al. Na, K-ATPase: A mur-zyme facilitating thermodynamic equilibriums at the membrane-interface. J Cell Physiol 2022.
Manoj KM, Gideon DA. Structural foundations for ex-plaining the physiological roles of murzymes embedded in diverse phospholipid membranes. Biochim Biophys Acta Biomembr 2022; 1864(10): 183981.
Manoj KM, Jaeken L, Bazhin NM, Tamagawa H, Kavdia M, Manekkathodi A. Murburn concept in cellular func-tion and bioenergetics, Part 1: Understanding murzymes at the molecular level. AIP Adv 2023; 13(12).
Manoj KM, Jaeken L, Bazhin NM, Tamagawa H, Gideon DA, Kavdia M. Murburn concept in cellular function and bioenergetics, Part 2: Understanding integrations-translations from molecular to macroscopic levels. AIP Adv 2023; 13(12).
Gideon DA, Parashar A, Robin J, Annadurai P, Nirusim-han V, Manoj KM. Do cyclooxygenases possess a mur-zyme activity? Biomed Rev 2021; 32: 47-59.
Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, et al. admet-SAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 2019; 35(6): 1067-9.
Morris GM, Huey R, Olson AJ. Using autodock for ligand-receptor docking. Curr Protoc Bioinformatics 2008; 24(1): 8.14.1-8.40.
Manoj KM, Parashar A, Venkatachalam A, Goyal S, Singh PG, Gade SK, et al. Atypical profiles and modulations of heme-enzymes catalyzed outcomes by low amounts of diverse additives suggest diffusible radicals’ obligatory involvement in such redox reactions. Biochimie 2016; 125: 91-111.
Parashar A, Gade SK, Potnuru M, Madhavan N, Manoj KM. The curious case of benzbromarone: insight into super-inhibition of cytochrome P450. PLoS One 2014; 9(3): e89967.
Manoj KM, Parashar A, Gade SK, Venkatachalam A. Functioning of microsomal cytochrome P450s: Mur-burn concept explains the metabolism of xenobiotics in hepatocytes. Front Pharmacol 2016; 7: 161.
Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic acid oxygenation by COX-1 and COX-2: mechanisms of catalysis and inhibition. J Biol Chem 1999; 274(33): 22903-6.
Smith WL, Urade Y, Jakobsson P-J. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem Rev 2011; 111(10): 5821-65.
Patrignani P, Patrono C. Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta Mol Cell Biol Lipids 2015; 1851(4): 422-32.
Van der Donk WA, Tsai A-L, Kulmacz RJ. The cyclooxy-genase reaction mechanism. Biochemistry 2002; 41(52): 15451-8.
Vecchio AJ, Simmons DM, Malkowski MG. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 2010; 285(29): 22152-63.
Yuan C, Sidhu RS, Kuklev DV, Kado Y, Wada M, Song I, et al. Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase ho-modimers. J Biol Chem 2009; 284(15): 10046-55.
Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 1996; 3(11): 927-33.
Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and-2. Prostaglandins Other Lipid Mediat 2002; 68: 115-28.
Sono M, Roach MP, Coulter ED, Dawson JH. Heme-containing oxygenases. Chem Rev 1996; 96(7): 2841-88.
Aboul-Enein HY, Kruk I, Lichszteld K, Michalska T, Kladna A, Marczynski S, et al. Scavenging of reactive oxygen species by N-substituted indole-2 and 3-carboxa-mides. Luminescence 2004; 19(1): 1-7.
Rowlinson SW, Crews BC, Lanzo CA, Marnett LJ. The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2): a putative L-shaped binding conformation uti-lizing the top channel region. J Biol Chem 1999; 274(33): 23305-10.
Lucido MJ, Orlando BJ, Vecchio AJ, Malkowski MG. Crystal structure of aspirin-acetylated human cyclooxyge-nase-2: insight into the formation of products with reversed stereochemistry. Biochemistry 2016; 55(8): 1226-38.
Saeed S, Mesaik M, Quadri J, Tasneem S, Motiwala A, Khalid U, et al. Interactions of cyclooxygenase inhibitors with reactive oxygen species. J Pharmacol Toxicol 2006; 1(2): 115-25.
Zarghi A, Arfaei S. Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res 2011; 10(4): 655.
Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldt CM, Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and− 2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 1996; 271(26): 15810-4.
Fitzpatrick F, Ennis M, Baze M, Wynalda M, McGee J, Liggett W. Inhibition of cyclooxygenase activity and plate-let aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem 1986; 261(32): 15334-8.
Huff RG, Bayram E, Tan H, Knutson ST, Knaggs MH, Richon AB, et al. Chemical and structural diversity in cyclooxygenase protein active sites. Chem Biodivers 2005; 2(11): 1533-52.
Parashar A, Manoj KM. Murburn precepts for cytochrome P450 mediated drug/xenobiotic metabolism and homeo-stasis. Curr Drug Metab 2021; 22(4): 315-26.
Cong Y-S, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66(3): 407-25.
Levin G, Duffin KL, Obukowicz MG, Hummert SL, Fujiwara H, Needleman P, et al. Differential metabolism of dihomo-γ-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J 2002; 365(2): 489-96.
Campbell WB, Falck JR, Okita JR, Johnson AR, Callahan KS. Synthesis of dihomoprostaglandins from adrenic acid (7, 10, 13, 16-docosatetraenoic acid) by human endothe-lial cells. Biochim Biophys Acta Lipids Lipid Metab 1985; 837(1): 67-76.
Mann CJ, Kaduce TL, Figard PH, Spector AA. Docosa-tetraenoic acid in endothelial cells: formation, retrocon-version to arachidonic acid, and effect on prostacyclin production. Arch Biochem Biophys 1986; 244(2): 813-23.
Malkowski MG, Thuresson ED, Lakkides KM, Rieke CJ, Micielli R, Smith WL, et al. Structure of eicosapen-taenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem 2001; 276(40): 37547-55.
Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. Different fatty acids compete with arachidonic acid for binding to the allosteric or catalytic subunits of cyclooxygenases to regulate prostanoid synthesis. J Biol Chem 2016; 291(8): 4069-78.
Shimokawa T, Kulmacz RJ, Dewitt DL, Smith WL. Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. J Biol Chem 1990; 265(33): 20073-6.
Tsai A-L, Hsi LC, Kulmacz RJ, Palmer G, Smith WL. Characterization of the tyrosyl radicals in ovine prostaglan-din H synthase-1 by isotope replacement and site-directed mutagenesis. J Biol Chem 1994; 269(7): 5085-91.
Wu G, Tsai A-L, Kulmacz RJ. Cyclooxygenase competitive inhibitors alter tyrosyl radical dynamics in prostaglandin H synthase-2. Biochemistry 2009; 48(50): 11902-11.
Bhattacharyya DK, Lecomte M, Rieke CJ, Garavito RM, Smith WL. Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phe-nylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem 1996; 271(4): 2179-84.
Rieke CJ, Mulichak AM, Garavito RM, Smith WL. The role of arginine 120 of human prostaglandin endoperoxide H synthase-2 in the interaction with fatty acid substrates and inhibitors. J Biol Chem 1999; 274(24): 17109-14.
Konkle ME, Blobaum AL, Moth CW, Prusakiewicz JJ, Xu S, Ghebreselasie K, et al. Conservative secondary shell substitution in cyclooxygenase-2 reduces inhibition by indomethacin amides and esters via altered enzyme dynamics. Biochemistry 2016; 55(2): 348-59.
Blobaum AL, Xu S, Rowlinson SW, Duggan KC, Baner-jee S, Kudalkar SN, et al. Action at a distance: mutations of peripheral residues transform rapid reversible inhibi-tors to slow, tight binders of cyclooxygenase-2. J Biol Chem 2015; 290(20): 12793-803.
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996; 384(6610): 644-8.
Viegas A, Manso J, Corvo MC, Marques MMB, Cabrita EJ. Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer differ-ence NMR. J Med Chem 2011; 54(24): 8555-62.
Stevens AM, Pawlitz JL, Kurumbail RG, Gierse JK, Moreland KT, Stegeman RA, et al. Crystallization of recombinant cyclo-oxygenase-2. J Cryst Growth 1999; 196(2-4): 350-5.
Schneider C, Boeglin WE, Brash AR. Identification of two cyclooxygenase active site residues, leucine 384 and glycine 526, that control carbon ring cyclization in prosta-glandin biosynthesis. J Biol Chem 2004; 279(6): 4404-14.
Sevigny MB, Li C-F, Alas M, Hughes-Fulford M. Glyco-sylation regulates turnover of cyclooxygenase-2. FEBS Lett 2006; 580(28-29): 6533-6.
Sevigny MB, Graham K, Ponce E, Louie MC, Mitchell K. Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors. Pharmacol Res 2012; 65(4): 445-50.
Yap YH-Y, Say Y-H. Resistance against apoptosis by the cellular prion protein is dependent on its glycosylation status in oral HSC-2 and colon LS 174T cancer cells. Cancer Lett 2011; 306(1): 111-9.
Greig GM, Francis DA, Falgueyret J-P, Ouellet M, Per-cival MD, Roy P, et al. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs. Mol Pharmacol 1997; 52(5): 829-38.
Levoin N, Blondeau C, Guillaume C, Grandcolas L, Chre-tien F, Jouzeau J-Y, et al. Elucidation of the mechanism of inhibition of cyclooxygenases by acyl-coenzyme A and acylglucuronic conjugates of ketoprofen. Biochem Pharmacol 2004; 68(10): 1957-69.
Laneuville O, Breuer DK, Xu N, Huang Z, Gage DA, Watson JT, et al. Fatty acid substrate speci昀椀cities of human prostaglandin-endoperoxide H synthase-1 and− 2: forma-tion of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from α-linolenic acid. J Biol Chem 1995; 270(33): 19330-6.
Venkatachalam A, Parashar A, Manoj KM. Functioning of drug-metabolizing microsomal cytochrome P450s: in silico probing of proteins suggests that the distal heme ‘active site’ pocket plays a relatively ‘passive role’ in some enzyme-substrate interactions. In Silico Pharmacol 2016; 4: 1-38.
Goltsov A, Swat M, Peskov K, Kosinsky Y. Cycle network model of prostaglandin H synthase-1. Pharmaceuticals 2020; 13(10): 265.
Thuresson ED, Lakkides KM, Smith WL. Different catalyti-cally competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. J Biol Chem 2000; 275(12): 8501-7.
Wu G, Lü J-M, Van Der Donk WA, Kulmacz RJ, Tsai A-L. Cyclooxygenase reaction mechanism of prostaglandin H synthase from deuterium kinetic isotope effects. J Inorg Biochem 2011; 105(3): 382-90.
Moltu SJ, Nordvik T, Rossholt ME, Wendel K, Chawla M, Server A, et al. Arachidonic and docosahexaenoic acid supplementation and brain maturation in preterm infants: a double blind RCT. Clin Nutr 2024; 43(1): 176-86.
Bai H-W, Zhu BT. Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids. J Lipid Res 2008; 49(12): 2557-70.
Rowlinson SW, Kiefer JR, Prusakiewicz JJ, Pawlitz JL, Kozak KR, Kalgutkar AS, et al. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem 2003; 278(46): 45763-9.
Gideon DA, Nirusimhan V, E JC, Sudarsha K, Manoj KM. Mechanism of electron transfers mediated by cy-tochromes c and b 5 in mitochondria and endoplasmic reticulum: classical and murburn perspectives. J Biomol Struct Dyn 2022; 40(19): 9235-52.
Manoj KM, Gideon DA, Parashar A. What is the role of lipid membrane-embedded quinones in mitochondria and chloroplasts? Chemiosmotic Q-cycle versus murburn reaction perspective. Cell Biochem Biophys 2021; 79(1): 3- 10.
Barbieri SS, Eligini S, Brambilla M, Tremoli E, Colli S. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc Res 2003; 60(1): 187-97.
Baek BS, Kim JW, Lee JH, Kwon HJ, Kim ND, Kang HS, et al. Age-related increase of brain cyclooxygenase activity and dietary modulation of oxidative status. J Gerontol A Biol Sci Med Sci 2001; 56(10): B426-B31.
Baumann J, Wurm G. Studies on the possible involvement of singlet oxygen and superoxide anion radicals in the cyclo-oxygenase reaction. Prostaglandins Leukot Med 1984; 14(1): 139-52.
Rahimtula A, O’Brien PJ. The possible involvement of singlet oxygen in prostaglandin biosynthesis. Biochem Biophys Res Commun 1976; 70(3): 893-9.
Tanabe T, Ullrich V. Prostacyclin and thromboxane syn-thases. J Lipid Mediat Cell Signal 1995; 12(2-3): 243-55.
Costa D, Gomes A, Lima JL, Fernandes E. Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs. Redox Rep 2008; 13(4): 153-60.
Kładna A, Aboul-Enein HY, Kruk I, Lichszteld K, Michal-ska T. Scavenging of reactive oxygen species by some nonsteroidal anti-inflammatory drugs and fenofibrate. Biopolymers 2006; 82(2): 99-105.
Kruk I, Aboul-Enein HY, Michalska T, Lichszteld K, Kubasik-Kladna K, Ölgen S. In vitro scavenging activ-ity for reactive oxygen species by N-substituted indole-2-carboxylic acid esters. Luminescence 2007; 22(4):379-86.
Landa P, Kutil Z, Temml V, Vuorinen A, Malik J, Dvora-kova M, et al. Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones. Planta Med 2012; 78(04): 326-33.
Nesaragi AR, Kamble RR, Dixit S, Kodasi B, Hoolageri SR, Bayannavar PK, et al. Green synthesis of therapeuti-cally active 1, 3, 4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies. Bioorg Med Chem Lett 2021; 43: 128112.
Villegas I, Martín M, La Casa C, Motilva V, Alarcón De La Lastra C. Effects of oxicam inhibitors of cyclooxy-genase on oxidative stress generation in rat gastric mucosa: A comparative study. Free Radic Res 2002; 36(7): 769-77.
Henry GE, Momin RA, Nair MG, Dewitt DL. Antioxidant and cyclooxygenase activities of fatty acids found in food. J Agric Food Chem 2002; 50(8): 2231-4.
Jachak SM. Cyclooxygenase inhibitory natural products: current status. Curr Med Chem 2006; 13(6): 659-78.
Amessis-Ouchemoukh N, Madani K, Falé PL, Serralheiro ML, Araújo MEM. Antioxidant capacity and phenolic contents of some Mediterranean medicinal plants and their potential role in the inhibition of cyclooxygenase-1 and acetylcholinesterase activities. Ind Crops Prod 2014; 53: 6-15.
Lee D-H, Kim Y-J, Kim H-H, Cho H-J, Ryu J-H, Rhee MH, et al. Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets. Biomolecules Ther 2013; 21(1): 54.
Laube M, Kniess T, Pietzsch J. Development of antioxi-dant COX-2 inhibitors as radioprotective agents for radia-tion therapy: A hypothesis-driven review. Antioxidants 2016; 5(2): 14.
Zielinski ZA, Pratt DA. Lipid peroxidation: kinetics, mechanisms, and products. J Org Chem 2017; 82(6): 2817-25.
Andrew D, Hager L, Manoj KM. The intriguing en-hancement of chloroperoxidase mediated one-electron oxidations by azide, a known active-site ligand. Biochem Biophys Res Commun 2011; 415(4): 646-9.
Parashar A, Manoj KM. Traces of certain drug molecules can enhance heme-enzyme catalytic outcomes. Biochem Biophys Res Commun 2012; 417(3): 1041-5.
Pryor WA, Houk KN, Foote CS, Fukuto JM, Ignarro LJ, Squadrito GL, Davies KJA. Free radicals in biology and medicine: From basic science to health implications. Am J Physiol Regul Integr Comp Physiol 2006; 291: R491-R511.
Smith WL, Murphy RC. Oxidized lipids formed non-enzymatically by reactive oxygen species. J Biol Chem 2008; 283(23): 15513-4.
Kaur M, Kaur B, Kaur J, Kaur A, Bhatti R, Singh P. Role of water in cyclooxygenase catalysis and design of anti-inflammatory agents targeting two sites of the enzyme. Sci Rep 2020; 10(1): 10764.
Ju Z, Li M, Xu J, Howell DC, Li Z, Chen F-E. Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years. Acta Pharm Sin B 2022; 12(6): 2790-807.
Chahal S, Rani P, Kiran, Sindhu J, Joshi G, Ganesan A, et al. Design and development of COX-II inhibitors: Cur-rent scenario and future perspective. ACS Omega 2023; 8(20): 17446-98.
Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 1999; 34(6): 879-86.
Powers SK, Nelson WB, Hudson MB. Exercise-induced oxidative stress in humans: cause and consequences. Free Radic Biol Med 2011; 51(5): 942-50.
Ristow M, Schmeisser S. Extending life span by increas-ing oxidative stress. Free Radic Biol Med 2011; 51(2):327- 36.
Mittler R. ROS are good. Trends Plant Sci 2017; 22(1):11- 9.
Hussain S, Iqbal A, Hamid S, Putra PP, Ashraf M. Identifying alkaline phosphatase inhibitory potential of cyclooxygenase-2 inhibitors: Insights from molecular docking, MD simulations, molecular expression analysis in MCF-7 breast cancer cell line and in vitro investiga-tions. Int J Biol Macromol 2024; 132: 721.
Alam A, Ali M, Rehman NU, Latif A, Shah AJ, Wazir NU, et al. Synthesis and characterization of biologi-cally active flurbiprofen amide derivatives as selective prostaglandin-endoperoxide synthase II inhibitors: In vivo anti-inflammatory activity and molecular docking. Int J Biol Macromol 2023; 228: 659-70.
Elmehbad NY, Mohamed NA, Abd El-Ghany NA, Abdel-Aziz MM. Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles. Int J Biol Macromol 2023; 253: 127277.
Mukherjee D, Ahmad R, Nayeem S. Molecular interplay promotes amelioration by quercetin during experimental hepatic inflammation in rodents. Int J Biol Macromol 2022; 222: 2936-47.
Zhou H, Feng L, Weng X, Wang T, Lu H, Bian Y, et al. Inhibition mechanism of cordycepin and ergosterol from Cordyceps militaris Link. against xanthine oxidase and cyclooxygenase-2. Int J Biol Macromol 2024; 258: 128898.
Email this article (Login required) 
